I’m pleased to welcome you to AstraZeneca’s new science blog, LabTalk. We’ve launched LabTalk to provide scientists with a digital forum to discuss cutting-edge science and innovation. It also presents a fresh and different way to engage with new and existing peers, partners and others.
Simply put, we’re going to discuss innovation in an innovative way which, I hope you will agree, is a welcome departure for big pharma. That said, this is my first and quite possibly my last blog post. While I’ll be faithfully following the blog, LabTalk’s meant to be a forum for the scientists…though I suspect I may have a thing or two to contribute along the way.